ROIV

#572
Roivant Sciences Ltd. Common Shares
29.5400 USD
+2.04%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
29.5100
29.5750
Rango anual
18.2700
30.3300
Cambio diario
+2.04%
Variación mensual
+3.67%
Variación en los últimos 6 meses
+61.33%
Cambio anual
+61.33%
Cierres anteriores
28.9500
Abrir
29.5300
Bid
Ask
Mínimo
29.5100
High
29.5750
Volumen
80
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 2020202120222023 TTM

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Noticias